We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West works by the side of our health care partners to understand patient needs and provide integrated delivery systems that optimize the effectiveness of drug delivery while enhancing the patient experience. Creative business models will ensure effective collaboration, either by leveraging West’s proprietary technologies or partnering with individual customers through the development process to apply West’s design, engineering and manufacturing skills to create customer-specific solutions.
We look for ways of combining innovations around drug containment (such as the use of Daikyo Crystal Zenith®polymer syringes and customized drug containers) with expertise and understanding of patient needs to create solutions for tomorrow’s therapies and medications. And we’ve done so with a platform of system technologies.
The SmartDose® patch injector technology platform has been designed to meet the packaging and delivery needs of today’s biologic drugs. The Crystal Zenith polymer cartridge system enables effective and repeatable injection performance through dimensional precision. Electronic capabilities within the SmartDose system allow for programmable dosing, as well as enabling user feedback and monitoring.
The SelfDoseTM injector technology platform offers a simple, manually-activated injection system, compatible with ISO standard prefilled syringes. It enables the user to control the rate of injection, and provides needle hiding before and after injection. It has been designed with the needs of patients in mind, particularly those suffering from rheumatoid arthritis or those with limited dexterity.
The ConfiDose® auto-injector technology platform offer options for a standard 1mL long syringe or a customized 1.5mL Crystal Zenith polymer syringe. The system offers automatic injection of a single dose within a short period of time, and have been designed to be compatible with a range of syringes and viscosities.
For more information about any of these platforms, contact West today.
Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd.
Daikyo Crystal Zenith® technology is licensed from Daikyo Seiko, Ltd.
SelfDoseTM, SmartDose® and ConfiDose® are trademarks or registered trademarks of West Pharmaceutical Services, Inc., or its affiliated companies, in the United States and other jurisdictions.
West seeks partners for its injector technology platforms. These platforms are intended to be used as an integrated system with drug filling and final assembly completed by the pharmaceutical/biotechnology company.
In a previous <a href="/blog/2012/may/lifecycle-planning"><span style="text-decoration: underline;">post</span></a>, my colleague Fran DeGrazio discussed lifecycle planning and the use of a single material for packaging components from development through commercialization. There has been a great deal of innovation around drug container materials. Although glass has been the traditional material of choice for drug containment, it has significant limitations including breakage, glass particulate, visual quality and functional performance.
Ever wondered what West’s cutting-edge product development facilities look like on the inside? Jeff Kyle, Sr. Director New Product Introduction, and Tom McLean, VP Delivery Systems R&D, take you behind the scenes of the Scottsdale, AZ plant.
<span style="color: #000000;">West has completed a preliminary study of its SmartDose® technology platform, which incorporates a Daikyo Crystal Zenith® (CZ) cartridge. The study evaluated multiple attributes of the technology and subjects’ experience with the self-application process. </span>
Polymeric container systems are not new to the pharmaceutical industry, and their benefits in terms of break resistance, cosmetic quality and dimensional precision have been recognized by many companies around the world who have chosen to use a polymer vial or syringe.
As global healthcare systems become more heavily reliant on radiopharmaceuticals for diagnostics and treatment, ensuring that the radioactive drug is safely contained for the duration of its shelf life has never been more vital.<br />
English
Chinese
